TransMedics Group Inc vs Telus Corporation Ordinary Shares — how do they compare? TransMedics Group Inc trades at $75.46 (market cap $2.74B), while Telus Corporation Ordinary Shares trades at $8.11 (market cap $12.52B). The key difference: Telus Corporation Ordinary Shares is far larger — about 4.6× TransMedics Group Inc's market cap, and Telus Corporation Ordinary Shares pays a 6.59% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold TransMedics Group Inc for 24 Days and Telus Corporation Ordinary Shares for 0 Days on average.
| TMDX | TU | |
|---|---|---|
Market Cap | $2.74B | $12.52B |
Volume | 1,025,926 | 6,655,034 |
Sector | Health | Media |
52-Week High | $150.42 | $15.33 |
52-Week Low | $61.99 | $7.72 |
Typical Hold Time | 24 Days | 0 Days |
Enterprise Value | $3.14B | $33.57B |
Dividend Yield | — | 6.59% |
Signals from Pluang's Aura AI — not financial advice
TMDX trades at $79.14, up 1.23% on the day, but faces a bearish technical outlook with recent earnings misses in Q1 and Q2 2026. The company maintains strong profitability with a 22.69% net income margin and 36.28% ROE, though 2026 projections show margin compression. Recent news highlights insider buying and a new CFO appointment, alongside multiple legal investigations into fiduciary duties.
The stock presents a mixed outlook; analyst consensus is bullish with a $99.63 price target, but near-term risks include earnings volatility, legal scrutiny, and a declining net cash flow trend. Investors should weigh solid fundamentals against execution and sentiment risks.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →Telus Corporation is a Canadian telecommunications company providing wireless, internet, television, and business connectivity services, with additional operations in digital healthcare through Telus Health and customer experience services through Telus Digital.
Read more on TU →